Items where Author is "Nahayati, M. A."

Article

(2026) Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS -infectious disease group. Multiple Sclerosis and Related Disorders. p. 106824. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2026) Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivity. Journal of Clinical Neuroscience. p. 10. ISSN 0967-5868

(2025) Investigating treatment alternatives for fingolimod in patients with multiple sclerosis developed refractory fingolimod-related genital Human Papilloma Virus (HPV) infection. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2024) Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study. Heliyon. p. 11.

(2024) Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial. Scientific Reports. p. 12. ISSN 2045-2322

(2024) Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study. Clinical Neurology and Neurosurgery. p. 7. ISSN 0303-8467

(2023) Evaluating the Influential Factors on the Time Interval between the Symptoms Onset and Diagnosis of Patients with Multiple Sclerosis. Multiple Sclerosis Journal. pp. 715-716. ISSN 1352-4585

(2023) Iranian specialists' approach to surgery in patients with multiple sclerosis. Current Journal of Neurology. pp. 96-102. ISSN 2717-011X

(2023) Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment Accepted. Current Journal of Neurology. pp. 1-7. ISSN 2717-011X

(2023) Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. Multiple Sclerosis and Related Disorders. p. 5. ISSN 2211-0348

(2022) COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran. VACCINES. ISSN 2076-393X J9 - VACCINES-BASEL